Cornel iridoid glycoside reduces infarct size measured by magnetic resonance imaging and improves neurological function after focal cerebral ischemia in rats

Conclusion CIG treatment, starting from 6 h after MCAO, reduced infarct size in the brain as measured by MRI and improved neurological function 2–28 days after focal cerebral ischemia in rats, suggesting that CIG could be a clinical application in improving stroke treatment.

http://link.springer.com/10.1007/s11655-015-2288-x

Source: Chinese Journal of Integrative Medicine - August 11, 2015 Category: Internal Medicine Source Type: research